Parola C, Salogni L, Vaira X, Scutera S, Somma P, et al. (2013) Selective Activation of Human Dendritic Cells by OM-85 through a NF-kB and MAPK Dependent Pathway. PLoS ONE 8(12): e82867. doi:10.1371/journal.pone.0082867.
Meredith, M,. Chiavaroli, C. Mechanism of action and therapeutic efficacy of the biotechnology-derived immunostimulating extract OM-85 in respiratory tract infections, Int. J. Biotechnology, 2007 Vol. 9, Nos. 3/4, pp.344–359.
Dang AT, Pasquali C, Ludigs K, Guarda G. OM-85 is an immunomodulator of interferon- production and inflammasome activity. Sci Rep. 2017 Mar 6;7:43844. doi: 10.1038/srep43844.
Roth M, Pasquali C, Stolz D, Tamm M. Broncho Vaxom (OM-85) modulates rhinovirus docking proteins on human airway epithelial cells via Erk1/2 mitogen activated protein kinase and cAMP. Plos one. 2017;12(11):e0188010. DOI: 10.1371/journal.pone.0188010.
Esposito, S., Bianchini, S., Bosis, S. et al. A randomized, placebo-controlled, double-blinded, single-centre, phase IV trial to assess the e€cacy and safety of OM-85 in children su¡ering from recurrent respiratory tract infections. J Transl Med 17, 284 (2019). https://doi.org/10.1186/s12967-019-2040-y.
Bitar MA et al. The role of OM-85 BV (Broncho-Vaxom) in preventing recurrent acute tonsillitis in children Int J Pediatr Otorhinolaryngol 2013;77:670–3.
Antunes KH, et al. Front Immunol 2022;13:867022; Antunes KH, Cassão G, Santos LD,Borges SG, Poppe J, Gonc¸alves JB,Nunes EdS, Recacho GF, Sousa VB,Da Silva GS, Mansur D, Stein RT, Pasquali C and De Souza APD (2022) Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection. Front. Immunol. 13:867022. doi: 10.3389/fimmu.2022.867022.
Pasquali C, et al. Enhanced mucosal antibody production and protection against respiratory infections following an orally administered bacterial extract Front Med (Lausanne) 2014;1:41.
Rossi GA, et al. Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice Ital J Pediatr 2018;44(1):112.
Pivniouk V, et al. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARSCoV-2 receptor expression J Allergy Clin Immunol 2021;149:923–933.
de la Torre González C, Pacheco Ríos A, Escalante Domínguez AJ, del Río Navarro BE. Metaanálisis comparativo de los inmunoestimulantes utilizados en pediatría en México. Revista Alergia México 2005;52(1):25-38.
Cao C, et al. Efficacy and safety of OM-85 in paediatric recurrent respiratory tract infections which could have a possible protective effect on COVID-19 pandemic: A meta-analysis Int J Clin Pract 2021;75:e13981.
Esposito S, et al. Impact of a mixed bacterial lysate (OM-85 BV) on the immunogenicity, safety and tolerability of inactivated influenzavaccine in children with recurrent respiratory tract infection. Vaccine 2014;32:2546–2552.
Esposito S, et al. Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study. Hum Vaccin Immunother. 2022 Nov 30;18(6):2106720.
Rossi. Immunomodulation Therapy Clinical Relevance of Bacterial Lysates OM-85 European Respiratory and Pulmonary Diseases. 2019. DOI: https://- doi.org/10.17925/ERPD.2019.5.1.17.
Navarro S, et al. The oral administration of bacterial extracts prevents asthma via the recruitment of Treg to the airways. Mucosal Immunology 2011; 4 (1):53-65.
Meng Q. BV alleviates persistent allergic rhinitis in patients by improving Th1 Th2 cytokine balance of nasal mucosa. Rhinology. 2019: 1-9.
Información para Prescribir BRONCHO-VAXOM® (F.F. Granulado) Reg. No. 635M2004 SSA IV.
Información para Prescribir BRONCHO-VAXOM® (F.F. Cápsula) Reg. No. 562M94 SSA IV.
De Benedetto F, et al. Multidiscip Respir Med. 2013;8:33.
Khameneh HJ, et al. Mucosal Immunol. 2024.
Manolova V, et al. J of Clin & Cell Immunol. 2017,8:2.
Luan H, et al. J of Interferon & Cytokine Res. 2014;34:526–536.
Huber C, et al. J of Immunol. 2005;174:5526–5536.
Roth M, et al. Can Respir J. 2021:8826645.
Roth, Block LH. Thorax. 2000;55:678–684.
Han RF, et al. Eur Rev Med Pharmacol Sci. 2016;20:2151–2155.
Han L, et al. Am J Rhinol Allergy. 2014;28:110–116.
Salzmann M, et al. J of Innate Immun. 2021. DOI: 10.1159/000519699.